CRSP SCHEDULE 13G/A: SEC filing

ARK Investment Management LLC

Filed with the SEC on · accession 0001104659-26-126825

CRSP filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. ARK Investment Management LLC filed an amended Schedule 13G reporting beneficial ownership of 10,056,844 shares (10.40%) of CRISPR Therapeutics AG common stock as of September 30, 2026. The stock moved -0.9% by the first close after the filing.

Summary of the filing

ARK Investment Management LLC filed an amended Schedule 13G reporting beneficial ownership of 10,056,844 shares (10.40%) of CRISPR Therapeutics AG common stock as of September 30, 2026. The filing is a passive investment disclosure with no intent to influence control of the company.

Key details

Shares beneficially owned by ARK Investment Management LLC$10.1M
Percent of class ownedPCT 10
Filer / beneficial ownerARK Investment Management LLC
Issuer / subject companyCRISPR Therapeutics AG
Ceo/cio of ark investment management llcCatherine D. Wood
Chief compliance officer of ark investment management llcKathleen Fontano

How CRSP stock reacted

Close before

$42.62

Nov 12, 2026

First close after

-0.89%

$42.24

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CRSP, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CRSP?

Click here

Frequently asked questions

What did CRSP file with the SEC on Nov 13, 2026?

CRSP filed a SCHEDULE 13G/A (SEC filing). ARK Investment Management LLC filed an amended Schedule 13G reporting beneficial ownership of 10,056,844 shares (10.40%) of CRISPR Therapeutics AG common stock as of September 30, 2026. The filing is a passive investment disclosure with no intent to influence control of the company.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did CRSP stock react to this filing?

CRSP closed at $42.62 before the filing and $42.24 on Nov 13, 2026 (-0.89%).

Other CRSP SEC filings

Get alerts when CRSP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days